217 related articles for article (PubMed ID: 11562199)
21. Feasibility of Affibody Molecule-Based PNA-Mediated Radionuclide Pretargeting of Malignant Tumors.
Honarvar H; Westerlund K; Altai M; Sandström M; Orlova A; Tolmachev V; Karlström AE
Theranostics; 2016; 6(1):93-103. PubMed ID: 26722376
[TBL] [Abstract][Full Text] [Related]
22. Design, Preparation, and Characterization of PNA-Based Hybridization Probes for Affibody-Molecule-Mediated Pretargeting.
Westerlund K; Honarvar H; Tolmachev V; Eriksson Karlström A
Bioconjug Chem; 2015 Aug; 26(8):1724-36. PubMed ID: 26086597
[TBL] [Abstract][Full Text] [Related]
23. Biological evaluation of avidin-based tumor pretargeting with DOTA-Triazole-Biotin constructed via versatile Cu(I) catalyzed click chemistry.
Uppal JK; Varshney R; Hazari PP; Chuttani K; Kaushik NK; Mishra AK
J Drug Target; 2011 Jul; 19(6):418-26. PubMed ID: 20678008
[TBL] [Abstract][Full Text] [Related]
24. PNA-PEG modified silicon platforms as functional bio-interfaces for applications in DNA microarrays and biosensors.
Cattani-Scholz A; Pedone D; Blobner F; Abstreiter G; Schwartz J; Tornow M; Andruzzi L
Biomacromolecules; 2009 Mar; 10(3):489-96. PubMed ID: 19191582
[TBL] [Abstract][Full Text] [Related]
25. Site-specific conjugation of recognition tags to trastuzumab for peptide nucleic acid-mediated radionuclide HER2 pretargeting.
Westerlund K; Vorobyeva A; Mitran B; Orlova A; Tolmachev V; Karlström AE; Altai M
Biomaterials; 2019 May; 203():73-85. PubMed ID: 30877838
[TBL] [Abstract][Full Text] [Related]
26. PNA as a Biosupramolecular Tag for Programmable Assemblies and Reactions.
Barluenga S; Winssinger N
Acc Chem Res; 2015 May; 48(5):1319-31. PubMed ID: 25947113
[TBL] [Abstract][Full Text] [Related]
27. Modulation of the pharmacokinetic properties of PNA: preparation of galactosyl, mannosyl, fucosyl, N-acetylgalactosaminyl, and N-acetylglucosaminyl derivatives of aminoethylglycine peptide nucleic acid monomers and their incorporation into PNA oligomers.
Hamzavi R; Dolle F; Tavitian B; Dahl O; Nielsen PE
Bioconjug Chem; 2003; 14(5):941-54. PubMed ID: 13129397
[TBL] [Abstract][Full Text] [Related]
28. Clickable peptide nucleic acids (cPNA) with tunable affinity.
Chouikhi D; Barluenga S; Winssinger N
Chem Commun (Camb); 2010 Aug; 46(30):5476-8. PubMed ID: 20571635
[TBL] [Abstract][Full Text] [Related]
29. Passive and active hepatoma tumor targeting of new N-(2-hydroxypropyl)methacrylamide copolymer conjugates: synthesis, characterization, and evaluation in vitro and in vivo.
Yuan J; Yuan B; Guo H; Zeng X; Wang X; Liao S; Li J; Jia Z; Song F; Wang F
J Biomater Sci Polym Ed; 2013; 24(12):1472-83. PubMed ID: 23829459
[TBL] [Abstract][Full Text] [Related]
30. Real time RNA transcription monitoring by Thiazole Orange (TO)-conjugated Peptide Nucleic Acid (PNA) probes: norovirus detection.
Tonelli A; Tedeschi T; Germini A; Sforza S; Corradini R; Medici MC; Chezzi C; Marchelli R
Mol Biosyst; 2011 May; 7(5):1684-92. PubMed ID: 21399831
[TBL] [Abstract][Full Text] [Related]
31. Preparation and comparative evaluation of
Vats K; Satpati D; Sharma R; Kumar C; Sarma HD; Banerjee S
J Labelled Comp Radiopharm; 2018 Feb; 61(2):68-76. PubMed ID: 29139598
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, biodistribution, and microsingle photon emission computed tomography (SPECT) imaging study of technetium-99m labeled PEGylated dendrimer poly(amidoamine) (PAMAM)-folic acid conjugates.
Zhang Y; Sun Y; Xu X; Zhang X; Zhu H; Huang L; Qi Y; Shen YM
J Med Chem; 2010 Apr; 53(8):3262-72. PubMed ID: 20350006
[TBL] [Abstract][Full Text] [Related]
33. Filter paper grafted with epoxide-based copolymer brushes for activation-free peptide nucleic acid conjugation and its application for colorimetric DNA detection.
Leekrajang M; Sae-Ung P; Vilaivan T; Hoven VP
Colloids Surf B Biointerfaces; 2019 Jan; 173():851-859. PubMed ID: 30551301
[TBL] [Abstract][Full Text] [Related]
34. Radionuclide Therapy of HER2-Expressing Human Xenografts Using Affibody-Based Peptide Nucleic Acid-Mediated Pretargeting: In Vivo Proof of Principle.
Westerlund K; Altai M; Mitran B; Konijnenberg M; Oroujeni M; Atterby C; de Jong M; Orlova A; Mattsson J; Micke P; Karlström AE; Tolmachev V
J Nucl Med; 2018 Jul; 59(7):1092-1098. PubMed ID: 29439013
[TBL] [Abstract][Full Text] [Related]
35. Sequence-specific DNA strand cleavage by 111In-labeled peptide nucleic acids.
He Y; Panyutin IG; Karavanov A; Demidov VV; Neumann RD
Eur J Nucl Med Mol Imaging; 2004 Jun; 31(6):837-45. PubMed ID: 14762696
[TBL] [Abstract][Full Text] [Related]
36. Targeted antisense radiotherapy and dose fractionation using a (177)Lu-labeled anti-bcl-2 peptide nucleic acid-peptide conjugate.
Liu D; Balkin ER; Jia F; Ruthengael VC; Smith CJ; Lewis MR
Nucl Med Biol; 2015 Sep; 42(9):704-10. PubMed ID: 26081917
[TBL] [Abstract][Full Text] [Related]
37. Predicting the biodistribution of radiolabeled cMORF effector in MORF-pretargeted mice.
Liu G; Dou S; He J; Liu X; Rusckowski M; Hnatowich DJ
Eur J Nucl Med Mol Imaging; 2007 Feb; 34(2):237-46. PubMed ID: 17021815
[TBL] [Abstract][Full Text] [Related]
38. Peptide-nucleic acids (PNAs): a tool for the development of gene expression modifiers.
Gambari R
Curr Pharm Des; 2001 Nov; 7(17):1839-62. PubMed ID: 11562312
[TBL] [Abstract][Full Text] [Related]
39. Comparative biodistributions and dosimetry of [¹⁷⁷Lu]DOTA-anti-bcl-2-PNA-Tyr³-octreotate and [¹⁷⁷Lu]DOTA-Tyr³-octreotate in a mouse model of B-cell lymphoma/leukemia.
Balkin ER; Liu D; Jia F; Ruthengael VC; Shaffer SM; Miller WH; Lewis MR
Nucl Med Biol; 2014 Jan; 41(1):36-42. PubMed ID: 24267052
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and Application of
Shank N; George Rosenker KM; Englund EA; Dix AV; Rastede EE; Appella DH
Methods Mol Biol; 2019; 1973():131-145. PubMed ID: 31016699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
